SCHEMBL6059472

SCHEMBL6059472

C=CCCc1ccc(-c2ccc3c(F)c(-c4ccc(OC)c(F)c4)ccc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.43
GRM2 Q14416 1/20 0.38
ALOX5 P09917 4/20 0.37
GABRA1 P14867 3/20 0.37
GABRB2 P47870 3/20 0.37
CNR2 P34972 2/20 0.37
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
TDP2 O95551 1/20 0.37
PTGS2 P35354 6/20 0.35
NAAA Q02083 1/20 0.35
PTGS1 P23219 3/20 0.34
ERN1 O75460 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
ALDH1A1 P00352 2/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162706 0.94 CYP17A1 (0.43) CYP17A1GRM2ALOX5GABRA1GABRB2
SCHEMBL3168521 0.94 GRM2 (0.41) CYP17A1GRM2ALOX5GABRA1GABRB2
SCHEMBL3171328 0.92 GRM2 (0.40) CYP17A1GRM2ALOX5GABRA1GABRB2
SCHEMBL3266266 0.88 ESR1 (0.36) CYP17A1GRM2ERN1
SCHEMBL3166712 0.88 ALOX5AP (0.32) CYP17A1NAAA
SCHEMBL3158249 0.88 ESR1 (0.31) CYP17A1
SCHEMBL3173288 0.88 PTGS2 (0.38) CYP17A1GRM2ALOX5GABRA1GABRB2
SCHEMBL6060275 0.87 CYP17A1 (0.46) CYP17A1GRM2ALOX5GABRA1GABRB2
SCHEMBL3153870 0.86 MAOB (0.39) CYP17A1GRM2ALDH1A1SMN1; SMN2
SCHEMBL6059490 0.85 ESR1 (0.40) CYP17A1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7145047-B2 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-12-05 US disclosed
EP-0952135-B1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK & CHEMICALS (JP) 2005-01-05 EP disclosed
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP disclosed
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-07-24 US disclosed
EP-1273562-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed
US-6468607-B1 MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same NLK, NOTCH1, NOTCH4 CYP17A1 425/4885GRM2 4698/4885ALOX5 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.